Company profile
BioLargo, Inc.
OTC: BLGO · Basic Materials · Chemicals - Specialty
#238 of 1,151 Basic Materials companies by revenuebottom-quartile growth
EA Score
40DFH 17DQ 70GM 38SS 65
v0.1 · 65/100 weight · provisional
↑ disclosure history, listing tenure · ↓ return on equity, Piotroski F
Methodology →Revenue TTM
$5.6M
Rev growth YoY (TTM)
-65.6%
Net income (FY)
-$15.2M
Employees
45
as of 2026-08-20
Market cap
$32.1M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$7.8M$7.8M2025
Net income-$15.2M-$15.2M2025
Operating income-$14.9M-$14.9M2025
Total assets$8.3M$8.3M2025
Liabilities$6.8M$6.8M2025
Equity$4.0M$4.0M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product74%
Service26%
By geography
Not disclosed.
The read
What is BioLargo, Inc.’s revenue?
BioLargo, Inc. booked $7.8M in FY2025 revenue, contracting 56% year over year — slower than 87% of Basic Materials companies we track, at a -195.6% net margin.
Peers · Basic Materials
Cabo Drilling Corp.——Talisker Resources Ltd.——Eagle Plains Resources Ltd.63CWestBond Enterprises Corporation——MustGrow Biologics Corp.40DH.E.R.C. Products Inc.——Neighbors
Orange →Key facts
CEODennis Calvert
SectorBasic Materials
IndustryChemicals - Specialty
HeadquartersWestminster, CA
ExchangeOTC: BLGO
Employees45
IPO date2007-03-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.